Skip to content

Drug interactions

Apalutamide + Selexipag

Severity: Moderate

Apalutamide and Selexipag: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Selexipag is metabolized by carboxylesterases and CYP2C8, and its active metabolite by UGT1A3 and UGT2B7. Apalutamide induces CYP enzymes and UGTs, so exposure may be reduced and pulmonary hypertension control may weaken.

What this interaction means in plain words

Apalutamide and Selexipag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Apalutamide belongs to Endocrine; Selexipag belongs to Cardiovascular.

Evidence level: Low

Why it happens

Apalutamide induces CYP2C8 and UGT enzymes, increasing clearance of selexipag and its active metabolite.

What to do

Monitor clinical response and symptoms of pulmonary arterial hypertension. Adjust the selexipag dose if needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apalutamide and Selexipag, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Apalutamide with Selexipag?

MediHelp rates the interaction as moderate. Apalutamide and Selexipag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Selexipag is metabolized by carboxylesterases and CYP2C8, and its active metabolite by UGT1A3 and UGT2B7. Apalutamide induces CYP enzymes and UGTs, so exposure may be reduced and pulmonary hypertension control may weaken.

How serious is the interaction between Apalutamide and Selexipag?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor clinical response and symptoms of pulmonary arterial hypertension. Adjust the selexipag dose if needed.

What other medicines interact with Apalutamide?

MediHelp also lists interactions of Apalutamide with, for example, Cabotegravir, Cobicistat, Doravirine. The full list is on the Apalutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in